Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Clinical trial NCT02452047 · COMPLETED
Trial details
- NCT number
- NCT02452047
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-21
- Primary completion
- 2017-09-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.